A Amanzholkyzy, Y Sagidanova, E Stankevicius, A Donayeva, U Sarsengali
Background: Environmental exposures are increasingly linked to reproductive dysfunctions such as endometriosis, ovarian insufficiency, and polycystic ovary syndrome (PCOS). Through endocrine disruption, oxidative stress, and epigenetic pathways, heavy metals (such as cadmium [Cd], lead [Pb], mercury [Hg], and arsenic [As]) and trace elements (such as zinc [Zn], copper [Cu], and selenium [Se]) may affect female fertility. Nevertheless, there are still few integrated assessments that address their combined consequences. The goal is to perform a critical evaluation and systematic analysis of epidemiological data about the link between reproductive health issues in women of reproductive age and exposure to heavy metals and trace elements.
Methods: A comprehensive literature search was carried out in PubMed, Scopus, Google Scholar, and Web of Science to locate articles published between 2010 and 2024. Included were observational human studies that looked at correlations between metal exposure and the reproductive results of females. The study's quality was assessed using the Newcastle-Ottawa Scale (NOS), and the review process adhered to PRISMA guidelines.
Findings: A total of twenty-three studies were included in the review: eleven case-control studies, eight cross-sectional studies, three cohort studies, and one analytical study. Cd, Pb, As, Hg, Cu, and Zn were the most frequently evaluated elements; these were usually detected in biological samples such blood, serum, or follicular fluid. While low Zn and Se levels were linked to endometrial diseases and a reduced ovarian reserve, elevated levels of Cd, Pb, and As were linked to an increased risk of PCOS and endometriosis. Inflammation and endocrine dysregulation were inversely correlated with protective trace elements, especially zinc and selenium. 17 studies had a high-quality rating (NOS score ≥7).
Conclusions: One important and controllable risk factor for the reproductive health of women is exposure to hazardous metals. It seems that preserving reproductive function depends on striking a balance between harmful and necessary components. To elucidate dose-response connections, synergistic effects, and possible therapeutic options, further prospective and mechanistic research is required.
背景:环境暴露与子宫内膜异位症、卵巢功能不全和多囊卵巢综合征(PCOS)等生殖功能障碍的关系越来越密切。通过内分泌干扰、氧化应激和表观遗传途径,重金属(如镉[Cd]、铅[Pb]、汞[Hg]和砷[as])和微量元素(如锌[Zn]、铜[Cu]和硒[Se])可能影响女性生育能力。然而,仍然很少有综合评估处理它们的综合后果。目标是对关于育龄妇女生殖健康问题与接触重金属和微量元素之间的联系的流行病学数据进行批判性评价和系统分析。方法:在PubMed、Scopus、谷歌Scholar、Web of Science等数据库中进行综合文献检索,定位2010 - 2024年间发表的文章。其中包括观察性人体研究,研究金属暴露与女性生殖结果之间的关系。研究质量采用纽卡斯尔-渥太华量表(NOS)进行评估,审查过程遵循PRISMA指南。结果:本综述共纳入23项研究:11项病例对照研究、8项横断面研究、3项队列研究和1项分析研究。Cd、Pb、As、Hg、Cu和Zn是最常被评价的元素;这些通常在血液、血清或卵泡液等生物样品中检测到。低锌和低硒水平与子宫内膜疾病和卵巢储备减少有关,而高镉、铅和砷水平与多囊卵巢综合征和子宫内膜异位症的风险增加有关。炎症和内分泌失调与保护性微量元素呈负相关,尤其是锌和硒。17项研究获得高质量评分(NOS评分≥7)。结论:有害金属接触是影响妇女生殖健康的一个重要的可控危险因素。似乎维持生殖功能取决于在有害成分和必要成分之间取得平衡。为了阐明剂量-反应关系、协同效应和可能的治疗选择,需要进一步的前瞻性和机制研究。
{"title":"HEAVY METAL TOXICITY VERSUS TRACE ELEMENT PROTECTION IN WOMEN'S REPRODUCTIVE HEALTH - A SYSTEMATIC REVIEW.","authors":"A Amanzholkyzy, Y Sagidanova, E Stankevicius, A Donayeva, U Sarsengali","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Environmental exposures are increasingly linked to reproductive dysfunctions such as endometriosis, ovarian insufficiency, and polycystic ovary syndrome (PCOS). Through endocrine disruption, oxidative stress, and epigenetic pathways, heavy metals (such as cadmium [Cd], lead [Pb], mercury [Hg], and arsenic [As]) and trace elements (such as zinc [Zn], copper [Cu], and selenium [Se]) may affect female fertility. Nevertheless, there are still few integrated assessments that address their combined consequences. The goal is to perform a critical evaluation and systematic analysis of epidemiological data about the link between reproductive health issues in women of reproductive age and exposure to heavy metals and trace elements.</p><p><strong>Methods: </strong>A comprehensive literature search was carried out in PubMed, Scopus, Google Scholar, and Web of Science to locate articles published between 2010 and 2024. Included were observational human studies that looked at correlations between metal exposure and the reproductive results of females. The study's quality was assessed using the Newcastle-Ottawa Scale (NOS), and the review process adhered to PRISMA guidelines.</p><p><strong>Findings: </strong>A total of twenty-three studies were included in the review: eleven case-control studies, eight cross-sectional studies, three cohort studies, and one analytical study. Cd, Pb, As, Hg, Cu, and Zn were the most frequently evaluated elements; these were usually detected in biological samples such blood, serum, or follicular fluid. While low Zn and Se levels were linked to endometrial diseases and a reduced ovarian reserve, elevated levels of Cd, Pb, and As were linked to an increased risk of PCOS and endometriosis. Inflammation and endocrine dysregulation were inversely correlated with protective trace elements, especially zinc and selenium. 17 studies had a high-quality rating (NOS score ≥7).</p><p><strong>Conclusions: </strong>One important and controllable risk factor for the reproductive health of women is exposure to hazardous metals. It seems that preserving reproductive function depends on striking a balance between harmful and necessary components. To elucidate dose-response connections, synergistic effects, and possible therapeutic options, further prospective and mechanistic research is required.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"210-216"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M Myrzakhanova, G Berdesheva, K Rustemova, Sh Kulbayeva, Y Lissitsyn, Zh Tleubergenova
Background: The potential of virtual reality (VR) in medical education in Kazakhstan proved substantial, offering innovative learning methods and creating secure, interactive training environments that facilitated the acquisition of both theoretical knowledge and practical skills.
Material and methods: This study aimed to evaluate the application and effectiveness of virtual reality in medical education through a survey conducted with 53 students and 20 teachers. To assess the perceptions and satisfaction with VR in medical education, a survey was conducted utilizing a scale from 1 to 10.
Results: Findings from the survey revealed that students perceived significant advantages in using virtual reality to grasp complex medical concepts and hone clinical skills. They appreciated the opportunity to apply theoretical knowledge in practice, the availability of high-quality content across various disciplines, and the safe learning conditions provided.
Conclusion: Teachers recognized virtual reality as a valuable educational tool but highlighted some challenges, including insufficient training and limited access to equipment. Addressing these obstacles is crucial for the successful integration of virtual reality into training programs, thereby unlocking its full potential and enhancing educational outcomes.
{"title":"TRANSFORMING MEDICAL EDUCATION IN KAZAKHSTAN: THE POTENTIAL OF VIRTUAL REALITY FOR ENHANCING THE LEARNING EXPERIENCE.","authors":"M Myrzakhanova, G Berdesheva, K Rustemova, Sh Kulbayeva, Y Lissitsyn, Zh Tleubergenova","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The potential of virtual reality (VR) in medical education in Kazakhstan proved substantial, offering innovative learning methods and creating secure, interactive training environments that facilitated the acquisition of both theoretical knowledge and practical skills.</p><p><strong>Material and methods: </strong>This study aimed to evaluate the application and effectiveness of virtual reality in medical education through a survey conducted with 53 students and 20 teachers. To assess the perceptions and satisfaction with VR in medical education, a survey was conducted utilizing a scale from 1 to 10.</p><p><strong>Results: </strong>Findings from the survey revealed that students perceived significant advantages in using virtual reality to grasp complex medical concepts and hone clinical skills. They appreciated the opportunity to apply theoretical knowledge in practice, the availability of high-quality content across various disciplines, and the safe learning conditions provided.</p><p><strong>Conclusion: </strong>Teachers recognized virtual reality as a valuable educational tool but highlighted some challenges, including insufficient training and limited access to equipment. Addressing these obstacles is crucial for the successful integration of virtual reality into training programs, thereby unlocking its full potential and enhancing educational outcomes.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"44-51"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To investigate the role of hypercorticism in the pathogenesis of acute radiation sickness (ARS) and under conditions of increased radioresistance, assessing the theoretical and clinical significance of impaired protein-steroid interactions.
Materials and methods: An analysis was conducted of experimental data from irradiated animal models: chinchilla rabbits (n=20), dogs (n=15), WISTAR rats (n=63), guinea pigs (n=49), and BALB/c mice (n=32). Some animals underwent adrenal autotransplantation. Fluorometric and gel filtration methods were used to assess protein-steroid interactions; total-body γ-irradiation was administered at doses inducing grade IV ARS. Data were statistically processed using Student's t-test.
Results: A biphasic adrenocortical response to radiation was observed in most species, whereas rabbits exhibited a monophasic decline in corticosteroid levels. During the peak of ARS, impaired corticosteroid-binding globulin (CBG) function led to increased levels of free, biologically active corticoids, even with normal or reduced total 11-oxycorticosteroids. A consistent radiobiological pattern was established: an increase in the free hormone fraction due to diminished CBG binding capacity. Adrenal autotransplantation prior to irradiation reduced corticoid levels, enhanced CBG binding capacity during ARS, and decreased free corticoid concentrations, resulting in a protective effect and increased radioresistance.
Conclusion: The findings underscore the critical role of corticosteroid regulation and CBG functional status in the body's response to radiation exposure. Modulation of adrenal activity and correction of protein-steroid interactions may be considered a promising strategy for enhancing radioresistance.
{"title":"HYPERCORTICISM IN THE PATHOGENESIS OF ACUTE RADIATION SICKNESS AND CONDITIONS OF INCREASED RADIORESISTANCE.","authors":"N Omelchuk","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the role of hypercorticism in the pathogenesis of acute radiation sickness (ARS) and under conditions of increased radioresistance, assessing the theoretical and clinical significance of impaired protein-steroid interactions.</p><p><strong>Materials and methods: </strong>An analysis was conducted of experimental data from irradiated animal models: chinchilla rabbits (n=20), dogs (n=15), WISTAR rats (n=63), guinea pigs (n=49), and BALB/c mice (n=32). Some animals underwent adrenal autotransplantation. Fluorometric and gel filtration methods were used to assess protein-steroid interactions; total-body γ-irradiation was administered at doses inducing grade IV ARS. Data were statistically processed using Student's t-test.</p><p><strong>Results: </strong>A biphasic adrenocortical response to radiation was observed in most species, whereas rabbits exhibited a monophasic decline in corticosteroid levels. During the peak of ARS, impaired corticosteroid-binding globulin (CBG) function led to increased levels of free, biologically active corticoids, even with normal or reduced total 11-oxycorticosteroids. A consistent radiobiological pattern was established: an increase in the free hormone fraction due to diminished CBG binding capacity. Adrenal autotransplantation prior to irradiation reduced corticoid levels, enhanced CBG binding capacity during ARS, and decreased free corticoid concentrations, resulting in a protective effect and increased radioresistance.</p><p><strong>Conclusion: </strong>The findings underscore the critical role of corticosteroid regulation and CBG functional status in the body's response to radiation exposure. Modulation of adrenal activity and correction of protein-steroid interactions may be considered a promising strategy for enhancing radioresistance.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"190-196"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L Lachashvili, M Khubua, M Jangavadze, Z Bedinasvili
Background: Gestational Diabetes Mellitus (GDM) is a significant medical problem worldwide and the cause of many complications for the mother and the foetus, in terms of pregnancy management and outcome. Early assessment of the risk of diabetes in pregnant women with hyperglycaemia is particularly important, as it allows timely preventive measures to help avoid potential complications Aim: Our aim was to identify microRNAs that could enable the assessment of diabetes risk in pregnant women with hyperglycaemia.
Methods: The study analyzed the expression of the following microRNAs: miR-132, miR-29a, miR-222, miR-93and miR-17-5p, from the blood samples of pregnant women with hyperglycaemia, with gestational diabetes mellitus, with type 1 or type 2 diabetes and healthy pregnant between 24 and 28 weeks of their pregnancy. The miR-17-5p was used as a reference.
Results: A significant difference in the miR-222 and miR-29a expression level was found in plasma samples. Compared to the control group Among pregnant patients with hyperglycaemia miR-222 and miR-29a in some sample exhibit increased levels while others show reduced levels-suggesting its potential for subgroup differentiation within this population. MiR-93 remains uniformly low in in Diabetes, GDM, Hyperglycaemia groups compared to the control group. A significant difference in the miR-93 expression level was found in plasma samples. miR-132 is also upregulated in GDM and diabetic patients, with the highest levels observed in the diabetic group, compared to the control group. In contrast, its expression fluctuates among pregnant women with hyperglycaemia.
Conclusion: The wide variability in the expression levels of miR-29a, miR-222 and miR-132 suggests that they may serve as useful predictive biomarkers for evaluating diabetes risk in hyperglycemic pregnant women. Further studies involving longitudinal follow-up of hyperglycaemic pregnant women are needed to determine the predictive value of these microRNAs.
{"title":"MIR-29A, MIR-222 AND MIR-132 IN THE BLOOD PLASMA OF PREGNANT WOMEN AS PREDICTORS OF GESTATIONAL DIABETES.","authors":"L Lachashvili, M Khubua, M Jangavadze, Z Bedinasvili","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Gestational Diabetes Mellitus (GDM) is a significant medical problem worldwide and the cause of many complications for the mother and the foetus, in terms of pregnancy management and outcome. Early assessment of the risk of diabetes in pregnant women with hyperglycaemia is particularly important, as it allows timely preventive measures to help avoid potential complications Aim: Our aim was to identify microRNAs that could enable the assessment of diabetes risk in pregnant women with hyperglycaemia.</p><p><strong>Methods: </strong>The study analyzed the expression of the following microRNAs: miR-132, miR-29a, miR-222, miR-93and miR-17-5p, from the blood samples of pregnant women with hyperglycaemia, with gestational diabetes mellitus, with type 1 or type 2 diabetes and healthy pregnant between 24 and 28 weeks of their pregnancy. The miR-17-5p was used as a reference.</p><p><strong>Results: </strong>A significant difference in the miR-222 and miR-29a expression level was found in plasma samples. Compared to the control group Among pregnant patients with hyperglycaemia miR-222 and miR-29a in some sample exhibit increased levels while others show reduced levels-suggesting its potential for subgroup differentiation within this population. MiR-93 remains uniformly low in in Diabetes, GDM, Hyperglycaemia groups compared to the control group. A significant difference in the miR-93 expression level was found in plasma samples. miR-132 is also upregulated in GDM and diabetic patients, with the highest levels observed in the diabetic group, compared to the control group. In contrast, its expression fluctuates among pregnant women with hyperglycaemia.</p><p><strong>Conclusion: </strong>The wide variability in the expression levels of miR-29a, miR-222 and miR-132 suggests that they may serve as useful predictive biomarkers for evaluating diabetes risk in hyperglycemic pregnant women. Further studies involving longitudinal follow-up of hyperglycaemic pregnant women are needed to determine the predictive value of these microRNAs.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"261-265"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M Rashova, S Akhmetova, B Tuleubaev, D Turebekova, A Koshanova, A Omenov, B Kambyl, Y Kossilova
Introduction: The study of acute toxicity is considered an integral part of any medical substance's preclinical evaluation. Changes in the psycho-emotional state are among the important indicators of the neurotoxic effects of various substances on animals and humans. Non-conflict methods of research are gaining increasing popularity as the most humane approaches with respect to animals, among which methods based on ethological approaches play a central role.
Materials and methods: A nanocellulose-based biocomposite was used as the implantable material. The study was conducted on 25 rats and included the formation of a defect in the mid-diaphysis of the femur followed by filling with either the biocomposite (10) or an autologous blood clot (10). Additionally, implantation into soft tissues was performed (5). The animals were observed for 14 days, during which clinical symptoms were assessed and open field and elevated plus maze tests were conducted.
Results: The nanocellulose-based biocomposite did not exhibit pyrogenic activity when implanted into bone and soft tissues. Assessment of several behavioral acts and states revealed no statistically significant differences in locomotor and exploratory activity between the experimental and control groups. The analysis of the indicators shows that the tested substance does not exert an acute toxic effect on the nervous system.
{"title":"ASSESSMENT OF CLINICAL SYMPTOMS OF ACUTE TOXICITY FOLLOWING THE IMPLANTATION OF A NANOCELLULOSE-BASED BIOCOMPOSITE.","authors":"M Rashova, S Akhmetova, B Tuleubaev, D Turebekova, A Koshanova, A Omenov, B Kambyl, Y Kossilova","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The study of acute toxicity is considered an integral part of any medical substance's preclinical evaluation. Changes in the psycho-emotional state are among the important indicators of the neurotoxic effects of various substances on animals and humans. Non-conflict methods of research are gaining increasing popularity as the most humane approaches with respect to animals, among which methods based on ethological approaches play a central role.</p><p><strong>Materials and methods: </strong>A nanocellulose-based biocomposite was used as the implantable material. The study was conducted on 25 rats and included the formation of a defect in the mid-diaphysis of the femur followed by filling with either the biocomposite (10) or an autologous blood clot (10). Additionally, implantation into soft tissues was performed (5). The animals were observed for 14 days, during which clinical symptoms were assessed and open field and elevated plus maze tests were conducted.</p><p><strong>Results: </strong>The nanocellulose-based biocomposite did not exhibit pyrogenic activity when implanted into bone and soft tissues. Assessment of several behavioral acts and states revealed no statistically significant differences in locomotor and exploratory activity between the experimental and control groups. The analysis of the indicators shows that the tested substance does not exert an acute toxic effect on the nervous system.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"127-137"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
O Markova, O Safonchyk, I Orlovska, O Kovalchuk, A Sukharieva, S Myrza, V Keidaliuk
Background: The development of e-pharmacies has significantly expanded public access to pharmaceutical products. At the same time, the rapid growth of e-commerce, the globalization of digital services and the expansion of cross-border trade in medicines have created new risks for consumers. These include violations of the conditions of storage and transportation of medicines, distribution of low-quality or counterfeit products, increased cases of self-medication, uncontrolled or illegal interference by third parties in the delivery process, etc. Aim: The purpose of the study is to analyze legal challenges and improve consumer protection mechanisms in the field of electronic commerce of medicines at the national and international levels.
Materials and methods: The study applies an interdisciplinary approach combining doctrinal legal analysis, comparative legal methodology, and empirical review of international regulatory practices. Legal acts, WHO and EU documents, FDA guidelines, and statistical data were examined to identify best practices for consumer protection in the field of e-commerce in medicines.
Results: The results of the study indicate that the legal regulation of relations in the field of electronic pharmaceutical services in the legislations of many countries is insufficient. It is emphasized that fragmented legal regulation, lack of harmonized international standards and insufficient supervision in the field of medicines circulation pose a significant threat to the health, safety and privacy of consumers.
Conclusions: It is concluded that effective consumer protection of digital services requires strengthening of regulatory requirements for e-commerce in medicines, in particular, introduction of clear rules for registration and licensing of online pharmacies, regulation of creation of relevant web resources, protection of personal data of consumers, etc. The author proposes a set of legal and institutional measures aimed at ensuring effective protection of the rights of consumers using the services of online pharmacies.
{"title":"PROTECTION OF CONSUMER RIGHTS IN THE FIELD OF ELECTRONIC COMMERCE OF MEDICINES.","authors":"O Markova, O Safonchyk, I Orlovska, O Kovalchuk, A Sukharieva, S Myrza, V Keidaliuk","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The development of e-pharmacies has significantly expanded public access to pharmaceutical products. At the same time, the rapid growth of e-commerce, the globalization of digital services and the expansion of cross-border trade in medicines have created new risks for consumers. These include violations of the conditions of storage and transportation of medicines, distribution of low-quality or counterfeit products, increased cases of self-medication, uncontrolled or illegal interference by third parties in the delivery process, etc. Aim: The purpose of the study is to analyze legal challenges and improve consumer protection mechanisms in the field of electronic commerce of medicines at the national and international levels.</p><p><strong>Materials and methods: </strong>The study applies an interdisciplinary approach combining doctrinal legal analysis, comparative legal methodology, and empirical review of international regulatory practices. Legal acts, WHO and EU documents, FDA guidelines, and statistical data were examined to identify best practices for consumer protection in the field of e-commerce in medicines.</p><p><strong>Results: </strong>The results of the study indicate that the legal regulation of relations in the field of electronic pharmaceutical services in the legislations of many countries is insufficient. It is emphasized that fragmented legal regulation, lack of harmonized international standards and insufficient supervision in the field of medicines circulation pose a significant threat to the health, safety and privacy of consumers.</p><p><strong>Conclusions: </strong>It is concluded that effective consumer protection of digital services requires strengthening of regulatory requirements for e-commerce in medicines, in particular, introduction of clear rules for registration and licensing of online pharmacies, regulation of creation of relevant web resources, protection of personal data of consumers, etc. The author proposes a set of legal and institutional measures aimed at ensuring effective protection of the rights of consumers using the services of online pharmacies.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"180-187"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background and aim: Hypertension is an unparalleled risk factor among cardiovascular diseases (CVD) and has been reported to target over 1.4 billion people globally. The Omega-3 polyunsaturated fatty acids (PUFAs), especially the eicosapentaenoic acid (EPA) and the docosahexaenoic acid (DHA) have been put forward as possible non-pharmacological interventions to control blood pressure because they are known to be vasoactive. The purpose of the systematic review was to summarize available evidence on the vasoactive properties of omega-3 PUFAs, and how these properties apply in managing hypertension and reduction of cardiovascular risk.
Methods: Systematic review was done in compliance with the PRISMA guidelines. The search in PubMed, Scopus, and Web of Science was conducted to identify the publications published between 2010 and 2025. Inclusion criteria were randomized controlled trials, cohort studies, and other related meta-analyses on the effect of EPA and/or DHA on blood pressure, and endothelial function, inflammation, lipid metabolism, and cardiovascular outcomes. Synthesis of data was done in the form of systematic narrative without quantitative pooling.
Results: Randomized controlled trial evidence has shown that omega-3 PUFA supplementation is linked with slight systolic and diastolic blood pressure decreases especially in hypertensive or those with high cardiometabolic risk persons. These effects have been shown to mediate via enhancement of endothelial nitric oxide bioavailability, reduction of vascular inflammation and positive remodeling of lipid profiles. Diversity of the outcomes of the studies was noticed and probably it is the difference in dosage, ratios of EPA:DHA, duration of the intervention, and the population specifics at the baseline.
Conclusion: Omega-3 PUFAs have shown promise as supplemental agents in the process of controlling hypertension and prevention of cardiovascular disease by a variety of complementary vasoactive pathways. Nonetheless, the heterogeneity of the studies does not allow conclusive findings on the best dosing strategies. Standardized hypertension-oriented large-scale randomized controlled trials conducted in the future are justified to improve clinical practice.
背景和目的:高血压是心血管疾病(CVD)中无与伦比的危险因素,据报道,全球有超过14亿人患有高血压。Omega-3多不饱和脂肪酸(PUFAs),特别是二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)已被提出作为可能的非药物干预措施来控制血压,因为它们已知具有血管活性。本系统综述的目的是总结现有的关于omega-3 PUFAs血管活性特性的证据,以及这些特性如何应用于控制高血压和降低心血管风险。方法:按照PRISMA指南进行系统评价。在PubMed, Scopus和Web of Science中进行了搜索,以确定2010年至2025年之间发表的出版物。纳入标准是随机对照试验、队列研究和其他有关EPA和/或DHA对血压、内皮功能、炎症、脂质代谢和心血管结局影响的荟萃分析。数据的综合以系统叙述的形式完成,没有定量汇集。结果:随机对照试验证据表明,补充omega-3 PUFA与轻微的收缩压和舒张压降低有关,特别是在高血压或心脏代谢高风险人群中。这些作用已被证明通过增强内皮一氧化氮的生物利用度,减少血管炎症和脂质谱的积极重塑来介导。研究结果的多样性被注意到,可能是剂量的差异,EPA:DHA的比例,干预的持续时间,以及基线时的人群特征。结论:Omega-3 PUFAs通过多种互补的血管活性途径在控制高血压和预防心血管疾病的过程中显示出作为补充剂的前景。尽管如此,这些研究的异质性并不能得出最佳给药策略的结论性结论。标准化的面向高血压的大规模随机对照试验将在未来进行,以改善临床实践。
{"title":"OMEGA-3 POLYUNSATURATED FATTY ACIDS AND HYPERTENSION: A REVIEW OF VASOACTIVE MECHANISMS AND IMPLICATIONS FOR CARDIOVASCULAR DISEASE.","authors":"M Jawhar, H Zainal, S Harun, B Saeed","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background and aim: </strong>Hypertension is an unparalleled risk factor among cardiovascular diseases (CVD) and has been reported to target over 1.4 billion people globally. The Omega-3 polyunsaturated fatty acids (PUFAs), especially the eicosapentaenoic acid (EPA) and the docosahexaenoic acid (DHA) have been put forward as possible non-pharmacological interventions to control blood pressure because they are known to be vasoactive. The purpose of the systematic review was to summarize available evidence on the vasoactive properties of omega-3 PUFAs, and how these properties apply in managing hypertension and reduction of cardiovascular risk.</p><p><strong>Methods: </strong>Systematic review was done in compliance with the PRISMA guidelines. The search in PubMed, Scopus, and Web of Science was conducted to identify the publications published between 2010 and 2025. Inclusion criteria were randomized controlled trials, cohort studies, and other related meta-analyses on the effect of EPA and/or DHA on blood pressure, and endothelial function, inflammation, lipid metabolism, and cardiovascular outcomes. Synthesis of data was done in the form of systematic narrative without quantitative pooling.</p><p><strong>Results: </strong>Randomized controlled trial evidence has shown that omega-3 PUFA supplementation is linked with slight systolic and diastolic blood pressure decreases especially in hypertensive or those with high cardiometabolic risk persons. These effects have been shown to mediate via enhancement of endothelial nitric oxide bioavailability, reduction of vascular inflammation and positive remodeling of lipid profiles. Diversity of the outcomes of the studies was noticed and probably it is the difference in dosage, ratios of EPA:DHA, duration of the intervention, and the population specifics at the baseline.</p><p><strong>Conclusion: </strong>Omega-3 PUFAs have shown promise as supplemental agents in the process of controlling hypertension and prevention of cardiovascular disease by a variety of complementary vasoactive pathways. Nonetheless, the heterogeneity of the studies does not allow conclusive findings on the best dosing strategies. Standardized hypertension-oriented large-scale randomized controlled trials conducted in the future are justified to improve clinical practice.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"266-271"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Y Tyravska, D Maltsev, V Moyseyenko, V Reshetylo, V Yakymenko
Introduction: Atherosclerotic cardiovascular diseases remain the leading cause of mortality worldwide, with chronic inflammation driving progression despite traditional lipid-lowering and antiplatelet therapy, leaving substantial residual cardiovascular risk. This study aimed to systematically analyze immunomodulator efficacy and safety in treating atherosclerosis and chronic cardiac diseases, determining therapeutic potential and associated risks.
Methods: A systematic search of Scopus, Web of Science, PubMed, Embase, and the Cochrane Library identified 264 records. After removing 134 duplicates and screening 130 unique records, 74 studies (20 randomized controlled trials, 16 systematic reviews/meta-analyses, 22 prospective cohort studies, 9 retrospective analyses, and 7 experimental studies) were selected that met the inclusion criteria and were included in the qualitative synthesis according to PRISMA 2020.
Results: Three main immunomodulator categories demonstrated cardiovascular efficacy: interleukin-1β inhibitors (canakinumab reduced events by 15%), small anti-inflammatory molecules (colchicine achieved 23-31% risk reduction), and interleukin-6 receptor antagonists (tocilizumab reduced infarct size by 12.4%). However, biological agents showed increased infectious complications, with canakinumab demonstrating statistically significant fatal infection increase. Immunomodulatory therapy represents transformative advancement targeting inflammatory mechanisms beyond lipid reduction. Colchicine emerged as priority drug for clinical implementation given optimal efficacy-cost ratio and favorable safety profile, while biologics face economic barriers exceeding $70,000 annually.
Conclusions: Long-term monitoring of immunosuppressive therapy safety profiles, particularly regarding infectious complications and oncological risks, remains critically important for future large-scale studies requiring decade-long surveillance in diverse populations.
导论:动脉粥样硬化性心血管疾病仍然是世界范围内死亡的主要原因,尽管传统的降脂和抗血小板治疗,慢性炎症驱动进展,留下大量残留的心血管风险。本研究旨在系统分析免疫调节剂治疗动脉粥样硬化和慢性心脏疾病的有效性和安全性,确定治疗潜力和相关风险。方法:系统检索Scopus、Web of Science、PubMed、Embase和Cochrane Library,确定264条记录。在剔除134项重复和筛选130项独特记录后,我们选择了74项符合纳入标准的研究(20项随机对照试验、16项系统评价/荟萃分析、22项前瞻性队列研究、9项回顾性分析和7项实验研究),并根据PRISMA 2020纳入定性综合。结果:三种主要的免疫调节剂类别显示出心血管功效:白介素-1β抑制剂(canakinumab可减少15%的事件),小抗炎分子(秋水仙碱可降低23-31%的风险)和白介素-6受体拮抗剂(tocilizumab可减少12.4%的梗死面积)。然而,生物制剂显示出增加的感染并发症,canakinumab显示有统计学意义的致命感染增加。免疫调节疗法代表了针对炎症机制的变革性进展,而不仅仅是脂质降低。秋水仙碱因其最佳的疗效成本比和良好的安全性而成为临床应用的优先药物,而生物制剂面临每年超过7万美元的经济壁垒。结论:长期监测免疫抑制治疗的安全性,特别是关于感染并发症和肿瘤风险,对于未来需要在不同人群中进行长达十年的监测的大规模研究至关重要。
{"title":"IMMUNOMODULATORS IN THE TREATMENT OF ATHEROSCLEROSIS AND OTHER CHRONIC HEART DISEASES: PROSPECTS AND RISKS.","authors":"Y Tyravska, D Maltsev, V Moyseyenko, V Reshetylo, V Yakymenko","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Atherosclerotic cardiovascular diseases remain the leading cause of mortality worldwide, with chronic inflammation driving progression despite traditional lipid-lowering and antiplatelet therapy, leaving substantial residual cardiovascular risk. This study aimed to systematically analyze immunomodulator efficacy and safety in treating atherosclerosis and chronic cardiac diseases, determining therapeutic potential and associated risks.</p><p><strong>Methods: </strong>A systematic search of Scopus, Web of Science, PubMed, Embase, and the Cochrane Library identified 264 records. After removing 134 duplicates and screening 130 unique records, 74 studies (20 randomized controlled trials, 16 systematic reviews/meta-analyses, 22 prospective cohort studies, 9 retrospective analyses, and 7 experimental studies) were selected that met the inclusion criteria and were included in the qualitative synthesis according to PRISMA 2020.</p><p><strong>Results: </strong>Three main immunomodulator categories demonstrated cardiovascular efficacy: interleukin-1β inhibitors (canakinumab reduced events by 15%), small anti-inflammatory molecules (colchicine achieved 23-31% risk reduction), and interleukin-6 receptor antagonists (tocilizumab reduced infarct size by 12.4%). However, biological agents showed increased infectious complications, with canakinumab demonstrating statistically significant fatal infection increase. Immunomodulatory therapy represents transformative advancement targeting inflammatory mechanisms beyond lipid reduction. Colchicine emerged as priority drug for clinical implementation given optimal efficacy-cost ratio and favorable safety profile, while biologics face economic barriers exceeding $70,000 annually.</p><p><strong>Conclusions: </strong>Long-term monitoring of immunosuppressive therapy safety profiles, particularly regarding infectious complications and oncological risks, remains critically important for future large-scale studies requiring decade-long surveillance in diverse populations.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"6-16"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M Madiyeva, G Bersimbekova, G Kanapiyanova, M Prilutskaya, A Mukanova
Background: Osteoporosis is a serious public health problem worldwide, especially among the aging population. It is characterized by low bone mineral density (BMD), which leads to an increased risk of fractures. Despite the growing burden, data on the prevalence of osteoporosis and related risk factors in Kazakhstan are limited. The purpose of this study was to assess the state of BMD and identify key risk factors associated with osteoporosis among adults aged 45 years and older in the Abay region of Kazakhstan.
Methods: The cross-sectional study was conducted from July 2023 to March 2024 with 367 women. Data collection included measurement of BMD using dual-energy X-ray absorptiometry (DXA), a standardized questionnaire adapted by the International Osteoporosis Foundation, and laboratory tests (vitamin D, calcium, and alkaline phosphatase levels). The participants were grouped by age and BMD status. Statistical analysis included the chi-square criterion or Fisher's exact criterion for categorical variables and the Mann-Whitney U-test or Kruskal-Wallis criterion for continuous variables. Logistic regression was used to study the relationship between low BMD and demographic factors, lifestyle, and nutrition.
Results: Osteopenia and osteoporosis were detected in 25.3% and 21.0% of participants, respectively, and their prevalence was significantly higher among people aged 56-65 years (p<0.004). Regression analysis showed that low BMD was significantly associated with older age (AOR 1.034; p=0.025), weight (AOR 0.975; p=0.071), lower BMI (AOR 0.989; p=0.764).
Conclusions: This study highlights the high prevalence of low BMD among middle-aged and older adults in the Abay region and underscores key modifiable risk factors, including older age, lower BMI, fracture history, and rheumatoid arthritis. These findings are essential for strengthening clinical diagnostic practices and guiding preventive strategies to reduce osteoporosis-related complications in the Kazakh population.
{"title":"ANALYSIS OF RISK FACTORS AND THEIR IMPACT ON BONE HEALTH STATUS IN KAZAKH POPULATIONS.","authors":"M Madiyeva, G Bersimbekova, G Kanapiyanova, M Prilutskaya, A Mukanova","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Osteoporosis is a serious public health problem worldwide, especially among the aging population. It is characterized by low bone mineral density (BMD), which leads to an increased risk of fractures. Despite the growing burden, data on the prevalence of osteoporosis and related risk factors in Kazakhstan are limited. The purpose of this study was to assess the state of BMD and identify key risk factors associated with osteoporosis among adults aged 45 years and older in the Abay region of Kazakhstan.</p><p><strong>Methods: </strong>The cross-sectional study was conducted from July 2023 to March 2024 with 367 women. Data collection included measurement of BMD using dual-energy X-ray absorptiometry (DXA), a standardized questionnaire adapted by the International Osteoporosis Foundation, and laboratory tests (vitamin D, calcium, and alkaline phosphatase levels). The participants were grouped by age and BMD status. Statistical analysis included the chi-square criterion or Fisher's exact criterion for categorical variables and the Mann-Whitney U-test or Kruskal-Wallis criterion for continuous variables. Logistic regression was used to study the relationship between low BMD and demographic factors, lifestyle, and nutrition.</p><p><strong>Results: </strong>Osteopenia and osteoporosis were detected in 25.3% and 21.0% of participants, respectively, and their prevalence was significantly higher among people aged 56-65 years (p<0.004). Regression analysis showed that low BMD was significantly associated with older age (AOR 1.034; p=0.025), weight (AOR 0.975; p=0.071), lower BMI (AOR 0.989; p=0.764).</p><p><strong>Conclusions: </strong>This study highlights the high prevalence of low BMD among middle-aged and older adults in the Abay region and underscores key modifiable risk factors, including older age, lower BMI, fracture history, and rheumatoid arthritis. These findings are essential for strengthening clinical diagnostic practices and guiding preventive strategies to reduce osteoporosis-related complications in the Kazakh population.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"23-30"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M Ismail, M Hassan, A Gherdaoui, M Alnaimi, R Altamimi, S Manimaran, M Jallo, R Muthukrishnan, P Kandakurthi, M Jaborova, F Shukurov, Sh Elsiddig, T Yousif, A Babker, A Osman, A Elamin
Background: Type 2 diabetes mellitus is associated with increased cardiovascular risk, with physical inactivity contributing significantly to metabolic dysfunction. This study aimed to investigate the association between physical activity status and cardiometabolic markers in patients with type 2 diabetes mellitus in the United Arab Emirates.
Methods: This cross-sectional study was conducted at Thumbay Labs, UAE, between January and October 2025. A total of 185 participants with type 2 diabetes were stratified into active (at least 150 minutes per week for more than 3 months) (n=99) and sedentary (n=86) groups based on physical activity levels. The active group was further subclassified by exercise type: aerobic (n=70), combined (n=17), and resistance training (n=11). Anthropometric measurements and biochemical parameters including fasting glucose, HbA1c, Fructosamine, fasting insulin, HOMA-IR, and lipid profile were assessed. Mann-Whitney U test, Kruskal-Wallis test, and Spearman's correlation were used for statistical analysis.
Results: The active group demonstrated significantly lower BMI (26.4 vs 28.6 kg/m², p<0.001), fasting glucose (127 vs 149 mg/dl, p<0.001), HbA1c (6.84% vs 8.07%, p<0.001), Fructosamine (303 vs 362 μmol/L, p<0.001), fasting insulin (9.03 vs 10.99 μU/mL, p=0.011), and HOMA-IR (3.0 vs 4.1, p<0.001) compared to the sedentary group. No significant differences were observed in lipid parameters. Among exercise subgroups, resistance training exhibited the most favorable metabolic profile with the lowest HbA1c (6.41%), BMI (23.01 kg/m²), and HOMA-IR (1.9). Correlation analysis revealed significant positive associations between BMI and glycemic markers as well as insulin resistance indices.
Conclusion: Physical activity is associated with significantly better glycemic control, insulin sensitivity, and body composition in patients with type 2 diabetes. Resistance training demonstrated particularly favorable metabolic outcomes; however, limited sample size restrict generalizability. These findings support the integration of regular physical activity into comprehensive diabetes care strategies.
背景:2型糖尿病与心血管风险增加相关,缺乏运动对代谢功能障碍有显著影响。本研究旨在探讨阿拉伯联合酋长国2型糖尿病患者身体活动状况与心脏代谢标志物之间的关系。方法:本横断面研究于2025年1月至10月在阿联酋Thumbay实验室进行。185名2型糖尿病患者根据身体活动水平被分为活动组(每周至少150分钟,持续3个月以上)(n=99)和久坐组(n=86)。活动组按运动类型进一步细分:有氧(n=70)、联合(n=17)和阻力训练(n=11)。评估人体测量和生化参数,包括空腹血糖、糖化血红蛋白、果糖胺、空腹胰岛素、HOMA-IR和血脂。采用Mann-Whitney U检验、Kruskal-Wallis检验和Spearman相关进行统计分析。结果:运动组的BMI显著降低(26.4 vs 28.6 kg/m²)。结论:运动与2型糖尿病患者更好的血糖控制、胰岛素敏感性和身体成分相关。阻力训练显示出特别有利的代谢结果;然而,有限的样本量限制了普遍性。这些发现支持将有规律的体育活动纳入全面的糖尿病护理策略。
{"title":"ASSOCIATION BETWEEN EXERCISE MODALITIES AND GLYCEMIC CONTROL IN TYPE 2 DIABETES.","authors":"M Ismail, M Hassan, A Gherdaoui, M Alnaimi, R Altamimi, S Manimaran, M Jallo, R Muthukrishnan, P Kandakurthi, M Jaborova, F Shukurov, Sh Elsiddig, T Yousif, A Babker, A Osman, A Elamin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Type 2 diabetes mellitus is associated with increased cardiovascular risk, with physical inactivity contributing significantly to metabolic dysfunction. This study aimed to investigate the association between physical activity status and cardiometabolic markers in patients with type 2 diabetes mellitus in the United Arab Emirates.</p><p><strong>Methods: </strong>This cross-sectional study was conducted at Thumbay Labs, UAE, between January and October 2025. A total of 185 participants with type 2 diabetes were stratified into active (at least 150 minutes per week for more than 3 months) (n=99) and sedentary (n=86) groups based on physical activity levels. The active group was further subclassified by exercise type: aerobic (n=70), combined (n=17), and resistance training (n=11). Anthropometric measurements and biochemical parameters including fasting glucose, HbA1c, Fructosamine, fasting insulin, HOMA-IR, and lipid profile were assessed. Mann-Whitney U test, Kruskal-Wallis test, and Spearman's correlation were used for statistical analysis.</p><p><strong>Results: </strong>The active group demonstrated significantly lower BMI (26.4 vs 28.6 kg/m², p<0.001), fasting glucose (127 vs 149 mg/dl, p<0.001), HbA1c (6.84% vs 8.07%, p<0.001), Fructosamine (303 vs 362 μmol/L, p<0.001), fasting insulin (9.03 vs 10.99 μU/mL, p=0.011), and HOMA-IR (3.0 vs 4.1, p<0.001) compared to the sedentary group. No significant differences were observed in lipid parameters. Among exercise subgroups, resistance training exhibited the most favorable metabolic profile with the lowest HbA1c (6.41%), BMI (23.01 kg/m²), and HOMA-IR (1.9). Correlation analysis revealed significant positive associations between BMI and glycemic markers as well as insulin resistance indices.</p><p><strong>Conclusion: </strong>Physical activity is associated with significantly better glycemic control, insulin sensitivity, and body composition in patients with type 2 diabetes. Resistance training demonstrated particularly favorable metabolic outcomes; however, limited sample size restrict generalizability. These findings support the integration of regular physical activity into comprehensive diabetes care strategies.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 369","pages":"217-223"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146194748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}